Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What radiation dose is safe in patients with non-small-cell lung cancer?

Nature Clinical Practice Oncology volume 4, pages 80–81 (2007)Cite this article

boxed-textKong F-M et al. (2006) Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65: 1075–1086

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Furuse K et al. (1999) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17: 2692–2699

    Article  CAS  Google Scholar 

  2. Marks LB et al. (2004) Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium. J Clin Oncol 22: 4329–4340

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. NA Larrier is a member of the faculty in the Department of Radiation Oncology, and LB Marks is Professor and Residency Program Director, Duke University Medical Center, Durham, NC, USA.,

    Nicole A Larrier & Lawrence B Marks

Authors
  1. Nicole A Larrier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lawrence B Marks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicole A Larrier.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Larrier, N., Marks, L. What radiation dose is safe in patients with non-small-cell lung cancer?. Nat Rev Clin Oncol 4, 80–81 (2007). https://doi.org/10.1038/ncponc0689

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0689

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing